Isis Pharmaceuticals, Inc. (ISIS) Earns $3.5 Million From Biogen Idec, Inc. (California) (BIIB)
5/10/2013 9:32:18 AM
More...
|
Not in Genentech (RHHBY)'s Shadow Anymore, Biogen Idec, Inc. (California) (BIIB) Makes Huge Comeback in Biotech
12/5/2012 8:04:43 AM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Receives $1.5 Million Milestone Payment from Biogen Idec, Inc. (Massachusetts) (BIIB) Related to Kinase Inhibitor Program
6/27/2012 12:19:11 PM
More...
|
Swedish Orphan Biovitrum's Agreement With Biogen Idec, Inc. (Massachusetts) (BIIB) Regarding Long-Lasting rFVIIIFc and rFIXFc Hemophilia Programs
2/6/2012 6:36:43 AM
More...
|
Burrill & Company Advises Samsung Corporation in Biosimilars Joint Venture Agreement With Biogen Idec, Inc. (California) (BIIB)
12/7/2011 10:13:00 AM
More...
|
Biogen Idec, Inc. (California) (BIIB) and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at International Society on Thrombosis and Haemostasis Meeting
7/26/2011 8:56:48 AM
More...
|
Biogen Idec, Inc. (California) (BIIB) Receives Approval in the European Union for AVONEX(R) PEN(TM)
6/7/2011 6:47:54 AM
More...
|
Biogen Idec, Inc. (California) (BIIB) to Present at the Bank of America (BAC) Merrill Lynch 2011 Healthcare Conference
5/5/2011 11:32:59 AM
More...
|
Amunix, Inc. Signs Research Collaboration With Biogen Idec, Inc. (California) (BIIB) for Next Generation Long-Lasting Blood Factor Products
4/13/2011 9:21:33 AM
More...
|
Biogen Idec, Inc. (California) (BIIB) to Name CEO in Coming Weeks; COO to Exit
6/8/2010 7:03:55 AM
More...
|
|